Agile TherapeuticsAGRX
13F holders, Q1 2024 (March 31)1holders
$0.34avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Agile Therapeutics Inc. (AGRX) in their 13F filings. The largest holder was Investor AB ($596).
- Company
- Agile Therapeutics Inc.
- CUSIP
- 00847L308
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 20 | $493K |
Ownership 1 holders
| Investor AB | 0.00% | No change | 1,754 | $596 |
"% of holder's portfolio" is AGRX's weight in each manager's 13F, not the share of Agile Therapeutics Inc. the manager owns.